[Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90].
Castaigne
S
S
Hôpital Saint-Louis, Paris, France.
Archimbaud
E
E
Fenaux
P
P
Bordessoule
D
D
Tilly
H
H
Simon
M
M
Dupriez
B
B
Auzanneau
G
G
Legros
M
M
Tertian
G
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D012074:Remission Induction / Q000379:methods
D000970:Antineoplastic Agents; D003561:Cytarabine; D005047:Etoposide; D008942:Mitoxantrone
Place de la double induction dans le traitement des leucémies aiguës myéloblastiques de l'adulte: résultats intermédiaires du protocole LAM90.